850759C

16:0-20:4 PE

1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine, chloroform

• Synonym(e): 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine; PAPE; PE(16:0/20:4(5Z,8Z,11Z,14Z)); 110638
• Empirische Formel (Hill-System): C₄₁H₇₄NO₈P
• CAS-Nummer: 70812-59-8
• Molekulargewicht: 740.00
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: powder
• Verpackung: pkg of 1 × 2.5 mL (850759C-25mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 850759C
• Konzentration: 10 mg/mL (850759C-25mg)
• Lipid-Typ: cardiolipins; phospholipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCC)=O

Beschreibung

Anwendung

16:0-20:4 PE has been used to determine its effect on oxidative burst in neutrophil granulocytes. It has also been used to determine its detergent solubility with equimolar concentration of sphingomyelin/cholesterol (SM/CHOL).

Verpackung

5 mL Clear Glass Sealed Ampule (850759C-25mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• Lagerklassenschlüssel: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): does not flash
• Flammpunkt (°C): does not flash